These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16047022)

  • 21. NMDA receptor-dependent signaling pathways that underlie amyloid beta-protein disruption of LTP in the hippocampus.
    Yamin G
    J Neurosci Res; 2009 Jun; 87(8):1729-36. PubMed ID: 19170166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders.
    Lau CG; Zukin RS
    Nat Rev Neurosci; 2007 Jun; 8(6):413-26. PubMed ID: 17514195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The development of amyloid beta protein deposits in the aged brain.
    Thal DR; Capetillo-Zarate E; Del Tredici K; Braak H
    Sci Aging Knowledge Environ; 2006 Mar; 2006(6):re1. PubMed ID: 16525193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of intracellular amyloid beta in Alzheimer's disease.
    Li M; Chen L; Lee DH; Yu LC; Zhang Y
    Prog Neurobiol; 2007 Oct; 83(3):131-9. PubMed ID: 17889422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytoplasmic gelsolin in pheochromocytoma-12 cells forms a complex with amyloid beta-protein.
    Ji L; Chauhan A; Chauhan V
    Neuroreport; 2008 Mar; 19(4):463-6. PubMed ID: 18287947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation.
    Song MS; Rauw G; Baker GB; Kar S
    Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers.
    Townsend M; Cleary JP; Mehta T; Hofmeister J; Lesne S; O'Hare E; Walsh DM; Selkoe DJ
    Ann Neurol; 2006 Dec; 60(6):668-76. PubMed ID: 17192927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amyloid beta-peptide Abeta(1-42) but not Abeta(1-40) attenuates synaptic AMPA receptor function.
    Parameshwaran K; Sims C; Kanju P; Vaithianathan T; Shonesy BC; Dhanasekaran M; Bahr BA; Suppiramaniam V
    Synapse; 2007 Jun; 61(6):367-74. PubMed ID: 17372971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloid-beta aggregation.
    Finder VH; Glockshuber R
    Neurodegener Dis; 2007; 4(1):13-27. PubMed ID: 17429215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evoking plasmin for beta-amyloid clearance.
    Zhao J; Pei G
    Cell Res; 2008 Aug; 18(8):803-4. PubMed ID: 18679173
    [No Abstract]   [Full Text] [Related]  

  • 32. Physiologic origins of age-related beta-amyloid deposition.
    Beach TG
    Neurodegener Dis; 2008; 5(3-4):143-5. PubMed ID: 18322373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Tat-Aβ1-6A2V(D) peptide against AD synaptopathy.
    Buccarello L; Borsello T
    Oncotarget; 2017 Feb; 8(7):10773-10774. PubMed ID: 28121622
    [No Abstract]   [Full Text] [Related]  

  • 34. Amyloid-beta: phylogenesis of a chameleon.
    Kontush A; Atwood CS
    Brain Res Brain Res Rev; 2004 Aug; 46(1):118-20. PubMed ID: 15297156
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum copper: a biomarker for Alzheimer disease?
    Bush AI; Strozyk D
    Arch Neurol; 2004 May; 61(5):631-2. PubMed ID: 15148135
    [No Abstract]   [Full Text] [Related]  

  • 36. The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis.
    Smith MA; Perry G
    J Neuropathol Exp Neurol; 1997 Feb; 56(2):217. PubMed ID: 9034378
    [No Abstract]   [Full Text] [Related]  

  • 37. The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis.
    Swaab DF; Salehi A
    J Neuropathol Exp Neurol; 1997 Feb; 56(2):216. PubMed ID: 9034377
    [No Abstract]   [Full Text] [Related]  

  • 38. The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis.
    Rosenblum WI
    J Neuropathol Exp Neurol; 1997 Feb; 56(2):213. PubMed ID: 9034375
    [No Abstract]   [Full Text] [Related]  

  • 39. The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis.
    Larner AJ
    J Neuropathol Exp Neurol; 1997 Feb; 56(2):214-5. PubMed ID: 9034376
    [No Abstract]   [Full Text] [Related]  

  • 40. Which synapses are affected in aging and what is the nature of their vulnerability? A commentary on "life span and synapses: will there be a primary senile dementia?".
    Morrison JH
    Neurobiol Aging; 2001; 22(3):349-50. PubMed ID: 11378237
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.